Erschienen:
American Medical Association (AMA), 2023
Erschienen in:
JAMA Neurology, 80 (2023) 12, Seite 1377
Sprache:
Englisch
DOI:
10.1001/jamaneurol.2023.3956
ISSN:
2168-6149
Entstehung:
Anmerkungen:
Beschreibung:
This cross-sectional study examines whether proposed myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) diagnostic criteria can exclude other diseases, such as multiple sclerosis, and rely on results of cell-based assays.